Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS.
about
A reflection on HIV/AIDS research after 25 yearsEffect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitroInhibition of human immunodeficiency virus syncytium formation and virus replication by castanosperminePathogenesis of human immunodeficiency virus infectionRetroviral coinfections: HIV and HTLV: taking stock of more than a quarter century of researchInhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosidesEscherichia coli surface display of single-chain antibody VRC01 against HIV-1 infection.Acquired immunodeficiency syndrome: more than a health-related dilemma.Molecular modeling study on the allosteric inhibition mechanism of HIV-1 integrase by LEDGF/p75 binding site inhibitors.Ultrastructural pathology of human immunodeficiency virus infection.Assessment of recent HIV-1 infection by a line immunoassay for HIV-1/2 confirmationHuman immunodeficiency virus-associated thrombocytopenia in infants.Hemophilia: an amazing 35-year journey from the depths of HIV to the threshold of cureToxicity, immunosuppressive effects and carcinogenic potential of volatile nitrites: possible relationship to Kaposi's sarcoma.Serum IgD elevation is an early marker of B cell activation during infection with the human immunodeficiency viruses.The Vancouver Lymphadenopathy-AIDS Study: 4. Effects of exposure factors, cofactors and HTLV-III seropositivity on number of helper T cells.The Vancouver Lymphadenopathy-AIDS Study: 3. Relation of HTLV-III seropositivity, immune status and lymphadenopathy.The Vancouver Lymphadenopathy-AIDS Study: 2. Seroepidemiology of HTLV-III antibodyNonrandom development of immunologic abnormalities after infection with human immunodeficiency virus: implications for immunologic classification of the diseaseInteraction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion.Profile of Beatrice H. Hahn.Serological relationship between reverse transcriptases from human T-cell lymphotropic viruses defined by monoclonal antibodies. Evidence for two forms of reverse transcriptases in the AIDS-associated virus, HTLV-III/LAV.Human retroviruses in leukaemia and AIDS: reflections on their discovery, biology and epidemiology.AIDS: an old disease from Africa?Seroepidemiology of HTLV-III antibody in Danish homosexual men: prevalence, transmission, and disease outcome.Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in humMonocyte function in the acquired immune deficiency syndrome. Defective chemotaxis.Partial restoration of impaired interleukin-2 production and Tac antigen (putative interleukin-2 receptor) expression in patients with acquired immune deficiency syndrome by isoprinosine treatment in vitro.Absence of cytotoxic antibody to human immunodeficiency virus-infected cells in humans and its induction in animals after infection or immunization with purified envelope glycoprotein gp120Deficiency of the autologous mixed lymphocyte reaction in patients with classic hemophilia treated with commercial factor VIII concentrate. Correlation with T cell subset distribution, antibodies to lymphadenopathy-associated or human T lymphotropicChallenges in the development of an HIV-1 vaccine.The Vancouver Lymphadenopathy-AIDS Study: 6. HIV seroconversion in a cohort of homosexual men.Human retroviruses after 20 years: a perspective from the past and prospects for their future control.Antibody response to human immunodeficiency virus in homosexual men. Relation of antibody specificity, titer, and isotype to clinical status, severity of immunodeficiency, and disease progressionDetection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridizationProbing chelation motifs in HIV integrase inhibitorsRetroperitoneal fibromatosis and acquired immunodeficiency syndrome in macaques. Pathologic observations and transmission studies.Severe combined immunodeficiency (SCID) in the mouse. Pathology, reconstitution, neoplasms.The neuropathology of AIDS. UCLA experience and review.
P2860
Q21245200-3E43F0EB-BE50-4119-B496-EC0F7E32BBF5Q24563651-5CF81D88-6526-4830-9169-396D7C822FBFQ24609215-DF92152F-77E9-41E1-B8BA-AD44EC82FE40Q24633025-43436090-C29C-4A79-A9FC-4A6A80DEAE4BQ24634681-4C0558F8-ADDD-44C3-A8D2-5055A0E05293Q26853678-4106B007-F2E0-40A3-AEC4-DF2F833D0D0CQ28360374-DCAF2816-4E73-4CD0-91B5-88CD46D6FD11Q30153279-510F91DF-E614-48B3-8D54-B4FEABF0EB54Q30383795-20A28EF8-3BC8-468A-88CB-47368216AF01Q31153312-258CC9FB-05A3-4048-A5B0-6E81EFFF7E7DQ33209535-07B2E5AB-77ED-4538-97A2-821091EF59A6Q33308261-9B039F4E-1C5F-49D0-863E-835DF1A00832Q33422747-472FB20E-EC30-4F86-8D07-FDBDE432EFA2Q34048559-9A15DB00-A92E-4965-B399-512169A5E66CQ34054836-44AAE361-82B7-486B-8C5B-3691B585C062Q34181086-C515A9D1-165B-4922-9FBA-6818EA3FED7AQ34299353-D03F6D88-D146-4BEC-A53B-FE7DBDE64C4BQ34299582-0B195AAF-41DF-4D4D-B203-5FBE78685312Q34299646-171B46A3-5B19-4C48-BC87-9F0CC684B65BQ34334948-5DF8FE20-95FE-4C35-A0AE-C3CD338F5EF0Q34335264-F0A7EE44-6E91-4953-A1A7-0A00966B1B0FQ34339526-D3C4A7FF-DD1B-45A9-9659-FF607C040BD0Q34385171-809D545D-369E-448A-BC87-BA3D93015CB8Q34389695-3EBDDD51-2012-49F0-B308-B070918FBBF9Q34550711-44C0B5D0-5C5F-4D6C-BDBD-FB52035038CDQ34552468-F27DE703-66FB-4385-BE72-3662D607888EQ34562317-885603EB-D4CA-4595-A069-EF34F02A8557Q34622519-0EFF949E-4348-4D2A-9465-423308A4FAE3Q34627351-4709F402-3CE9-47D4-9DC1-BB8574CB21B8Q34628114-EFA3B101-E61D-49BD-A77F-E15F6A1AFE65Q34629604-003423AD-1E02-441E-99C0-A9A6283680F4Q34657290-0C6B4989-2A29-4CF5-98B2-32831EB8C462Q34729798-91463752-7094-45F6-ACBF-1146BA89627DQ34792498-A2297B0B-87AB-4CE8-9CE0-6229C8053DD0Q35576665-85D1ADE5-33D3-444C-9059-934373CD3113Q35589022-BCEA647A-F7CA-4A4D-A5A4-8E3986A5614AQ35786972-38B9523C-4073-4413-B863-96FDAE1FAE90Q35835055-2EA83054-0A82-4250-8B75-8A4CA4EF7176Q35835313-EDE56A8D-75C2-4726-88F0-28A8FB5409E8Q35836258-D766026E-1EED-4045-AE77-4B5F3FB8DA3B
P2860
Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS.
description
1984 nî lūn-bûn
@nan
1984 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
name
Serological analysis of a subg ...... TLV-III) associated with AIDS.
@ast
Serological analysis of a subg ...... TLV-III) associated with AIDS.
@en
Serological analysis of a subgroup of human T-lymphotropic retroviruses
@nl
type
label
Serological analysis of a subg ...... TLV-III) associated with AIDS.
@ast
Serological analysis of a subg ...... TLV-III) associated with AIDS.
@en
Serological analysis of a subgroup of human T-lymphotropic retroviruses
@nl
prefLabel
Serological analysis of a subg ...... TLV-III) associated with AIDS.
@ast
Serological analysis of a subg ...... TLV-III) associated with AIDS.
@en
Serological analysis of a subgroup of human T-lymphotropic retroviruses
@nl
P2093
P356
P1433
P1476
Serological analysis of a subg ...... TLV-III) associated with AIDS.
@en
P2093
Sarngadharan MG
Schüpbach J
P304
P356
10.1126/SCIENCE.6200937
P407
P50
P577
1984-05-01T00:00:00Z